I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Optimizing VLP production in gene therapy: Opportunities an..:
Leopold Zehetner (Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna)
;
Diana Széliová (Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna)
;
Barbara Kraus (Biotherapeutics Process Development, Baxalta Innovations GmbH, a Part of Takeda Companies)
...
hdl:11353/10.2008536. , 2023
Link:
https://doi.org/10.1002/biot.202200636
RT Journal T1
Optimizing VLP production in gene therapy: Opportunities and challenges for in silico modeling
UL https://suche.suub.uni-bremen.de/peid=base-ftunivwiendc:oai:phaidra.univie.ac.at:o:2008536&Exemplar=1&LAN=DE A1 Leopold Zehetner (Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna) A1 Diana Széliová (Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna) A1 Barbara Kraus (Biotherapeutics Process Development, Baxalta Innovations GmbH, a Part of Takeda Companies) A1 Michael Graninger (Biotherapeutics Process Development, Baxalta Innovations GmbH, a Part of Takeda Companies) A1 Jürgen Zanghellini (Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna) A1 Juan A. Hernandez Bort (Biotherapeutics Process Development, Baxalta Innovations GmbH, a Part of Takeda Companies) PB Wiley YR 2023 K1 gene therapy K1 genome-scale metabolic model K1 HEK-293 K1 omics K1 virus-like particle JF hdl:11353/10.2008536 LK http://dx.doi.org/https://doi.org/10.1002/biot.202200636 DO https://doi.org/10.1002/biot.202200636 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)